Summary Opexa Therapeutics Inc (Opexa), formerly PharmaFrontiers Corp is a biotechnology company that develops personalized immunotherapies for the treatment of autoimmune disorders, rheumatoid arthritis, diabetes and heart failure. The company’s products include Tcelna, a T-cell immunotherapy used for the treatment of secondary progressive multiple sclerosis; OPX-212, for neuromyelitis optica. It uses T-cell technology platform for the development of patient-specific T-cell therapies. The company operates through its manufacturing facility, and research and development facilities. It operates in the US and Canada. Opexa is headquartered in Woodlands, Texas, the US.
Opexa Therapeutics Inc (OPXA) - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.
GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.
Scope - Financial Deals - Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships. - Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period. - Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc. - Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America. - Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector. - Major Deals - Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios. - Business Description - A brief description of the company’s operations. - Key Employees - A list of the key executives of the company. - Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company. - Key Competitors - A list of the key competitors of the company. - Key Recent Developments - A brief on recent news about the company.
Reasons to Buy Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements - The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.
Understand the company’s business segments’ expansion / divestiture strategy - The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.
Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company - Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.
Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers. - The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.
Stay up-to-date on the major developments affecting the company - Recent developments concerning the company presented in the profile help you track important events.
Gain key insights into the company for academic or business research - Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.
Note*: Some sections may be missing if data is unavailable for the company.
Our reports have been used by over 10K customers, including:
Autism (Central Nervous System) - Drugs in Development, 2021 Summary This latest Pharmaceutical and Healthcare disease pipeline guide Autism - Drugs in Development, 2021, provides an overview of the Autism (Central Nervous System) pipeline landscape. Autism, also known as complex developmental...
Community Acquired Pneumonia (Infectious Disease) - Drugs in Development, 2021 Summary This latest Pharmaceutical and Healthcare disease pipeline guide Community Acquired Pneumonia - Drugs in Development, 2021, provides an overview of the Community Acquired Pneumonia (Infectious Disease) pipeline...
207 pages •
By Global Industry Analysts
• Apr 2021
Abstract:
- Global Wearable Injectors Market to Reach $9.2 Billion by 2027
- Amid the COVID-19 crisis, the global market for Wearable Injectors estimated at US$4.8 Billion in the year 2020, is projected to reach a revised size of US$9.2 Billion by 2027, growing at aCAGR of 9.7% over the period 2020-2027. On-Body injectors,...
133 pages •
By Global Industry Analysts
• Apr 2021
Abstract:
- Global Pneumonia Therapeutics Market to Reach $22.5 Billion by 2027
- Amid the COVID-19 crisis, the global market for Pneumonia Therapeutics estimated at US$14.5 Billion in the year 2020, is projected to reach a revised size of US$22.5 Billion by 2027, growing at a CAGR of 6.5% over the analysis period...
182 pages •
By Global Industry Analysts
• Apr 2021
Abstract:
- Global Neuroprotection Therapeutics Market to Reach $85.1 Billion by 2027
- Amid the COVID-19 crisis, the global market for Neuroprotection Therapeutics estimated at US$53.6 Billion in the year 2020, is projected to reach a revised size of US$85.1 Billion by 2027, growing at a CAGR of 6.8% over the analysis...
279 pages •
By Global Industry Analysts
• Apr 2021
Abstract:
- Global Gout Therapeutics Market to Reach $9.7 Billion by 2027
- Amid the COVID-19 crisis, the global market for Gout Therapeutics estimated at US$3.7 Billion in the year 2020, is projected to reach a revised size of US$9.7 Billion by 2027, growing at a CAGR of 14.8% over the analysis period 2020-2027....
280 pages •
By Global Industry Analysts
• Apr 2021
Abstract:
- Global Hunter Syndrome Treatment Market to Reach $1.5 Billion by 2027
- Amid the COVID-19 crisis, the global market for Hunter Syndrome Treatment estimated at US$966.6 Million in the year 2020, is projected to reach a revised size of US$1.5 Billion by 2027, growing at a CAGR of 6.1% over the analysis period...
385 pages •
By Global Industry Analysts
• Apr 2021
Abstract:
- Global Peptide Therapeutics Market to Reach $47 Billion by 2027
- Amid the COVID-19 crisis, the global market for Peptide Therapeutics estimated at US$27.2 Billion in the year 2020, is projected to reach a revised size of US$47 Billion by 2027, growing at aCAGR of 8.1% over the period 2020-2027. Innovative,...
129 pages •
By Global Industry Analysts
• Apr 2021
Abstract:
- Global Post-Traumatic Stress Disorder (PTSD) Therapeutics Market to Reach $3.1 Billion by 2027
- Amid the COVID-19 crisis, the global market for Post-Traumatic Stress Disorder (PTSD) Therapeutics estimated at US$2.3 Billion in the year 2020, is projected to reach a revised size of US$3.1 Billion by 2027,...
100 pages •
By Global Industry Analysts
• Apr 2021
Abstract:
- Global Systemic Psoriasis Therapeutics Market to Reach $19.1 Billion by 2027
- Amid the COVID-19 crisis, the global market for Systemic Psoriasis Therapeutics estimated at US$10.7 Billion in the year 2020, is projected to reach a revised size of US$19.1 Billion by 2027, growing at a CAGR of 8.6% over the...
Therapy
Autoimmune Disease
World
China
United States
By continuing to use this site you consent to the use of cookies on your device as described in our Cookie Policy unless you have disabled them.
You can change your Cookie Settings at any time but parts of our site will not function correctly without them.